NCT00752531.
Methods | Randomised intervention trial |
Participants | Moderate to severe COPD according to NHLBI/WHO GOLD classification (stages II to III) |
Interventions | (HAT) |
Outcomes | Clinical health, including lung function and respiratory symptoms, COPD‐related quality of life, exercise tolerance, urgent healthcare utilisation, self‐efficacy for COPD patients, activities of daily living |
Notes | Unable to find publication |